Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe.
By R. Köck, K. Becker, B. Cookson, J. V. Gemert-Pijnen, S. Harbarth, J. Kluytmans, M. Mielke, G. Peters, R. Skov, M. Struelens and 4 more. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2010
640 citations recorded by the source corpus.
Methicillin-resistant Staphylococcus aureus (MRSA) isa major cause of healthcare- and community-associated infections worldwide. Within the healthcare setting alone, MRSA infections are estimated to affect more than 150,000 patients annually in the European Union (EU), resulting in attributable extra in-hospital costs of EUR 380 million for EU healthcare systems. Pan-European surveillance data on bloodstream infections show marked variability among EU Member States in the proportion of S. aureus that are methicillin-resistant, ranging from less than 1% to more than 50%. In the past five years, the MRSA bacteraemia rates have decreased significantly in 10 EU countries with higher endemic rates of MRSA infections. In addition to healthcare-associated infections, new MRSA strains have recently emerged as community and livestock-associated human pathogens in most EU Member States. The prevention and control of MRSA have therefore been identified as public health priorities in the EU. In this review, we describe the current burden of MRSA infections in healthcare and community settings across Europe and outline the main threats caused by recent changes in the epidemiology of MRSA. Thereby, we aim at identifying unmet needs of surveillance, prevention and control of MRSA in Europe.
Subfields: Clinical Biochemistry, Infectious Diseases, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/d96e1e05763f3a80c00a7062e807d08321f2c95f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Biochemistry
In Infectious Diseases
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology (2018, background): “Infections with HA-MRSA are often clinically difficult to treat due to their resistance to multiple classes of antibiotics, creating an enormous economic and logistical problem, with significant mortality and morbidity (390).”